Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Identify index funds with top risk-adjusted returns to guide smarter allocations. Learn criteria for selecting high-efficiency funds.
28,465 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Bitcoin trades in a narrow band near $68,000 as policy shifts test crypto risk. A 150-day clock starts on tariff dura...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
Broadcom’s latest price move came on the back of a price-target cut and AI optimism colliding with caution. This guid...
Oil prices posted their largest quarterly price decline in six years during Q2 2026, as easing supply constraints and...
Bitcoin shows signs of shifting away from high-beta behavior, yet it has not become a reliable safe haven, according ...
The AI boom has cooled, but the backbone of AI—data centers and cloud services—remains essential. This guide highligh...
A fresh take on spotting a possible dark-horse in the driverless vehicle arena. Learn the signals, risks, and how to ...
Bitcoin faces renewed volatility as veteran trader Peter Brandt hints at moving BTC into gold, sparking a fresh debat...
A Tokyo-based lender is weighing a potential Jefferies takeover, a move that could reshape cross-border banking and i...
VantageScore unveils a new 5.0 model designed to improve credit risk assessment across Equifax, Experian and TransUni...
The CDC has expanded its Ebola response after the WHO declared an international public health emergency, deploying mo...